Hydrophilized membrane and process for hydrophilization thereof

• US 20060243657A1
• Filed: 06/29/2006
• Published: 11/02/2006
• Est. Priority Date: 10/24/2000
• Status: Abandoned Application

• Current Assignee: Kaneka Corporation
• Original Assignee: Kaneka Corporation
• Inventors: Tani, Nobutaka, Oide, Yasuhito, Kobayashi, Akira, Fujita, Koji
• Application Number:
  US11/476,598
• Publication Number:
  US 20060243657A1
• Time in Patent Office: Days
• US Class Current: 210/500.270
• CPC Class Codes: A61L 31/06 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L31/041 takes precedence
• CPC Class Codes: A61L 31/146 Porous materials, e.g. foams or sponges
• CPC Class Codes: B01D 67/0088 Physical treatment with compounds, e.g. swelling, coating or impregnation
• CPC Class Codes: C08L 81/06 Polysulfones; Polyethersulfones

Abstract

The present invention relates to a hydrophilized membrane which has greatly suppressed adhesion of blood cells such as erythrocytes, leukocytes and blood platelets within blood, by easily conducting hydrophilization of a hydrophobic porous membrane, and a process for the hydrophilization. The present invention relates to a hydrophilized hydrophobic porous membrane which is obtained by impregnating a medical supply of which the part which comes into contact with blood is hydrophobic in a solution of a substance having surface activity, then rinsing in a solvent into which the surfactant is soluble, and adsorbing an extremely small amount of the substance having surface activity to the surface of the part which comes into contact with blood, wherein the adhesion of blood cells such as erythrocytes, leukocytes and blood platelets within blood is greatly suppressed. The present invention also relates to a process for hydrophilization.

Claims

1-20. -20. (canceled)

21. A process for suppressing blood cell adhesion by using a hydrophilized porous membrane for medical use, wherein the hydrophilized porous membrane comprises:

a hydrophobic porous membrane, and

a substance having surface activity, said substance being adsorbed on a surface of the hydrophobic porous membrane in an amount of 0.02 mg to 250 mg per dry weight (g) of said membrane, and

the substance having surface activity is at least one member selected from the group consisting of purified vitelline lecithin, highly purified vitelline lecithin, purified soybean lecithin and hydrogenated polyoxyethylene castor oil.

22. The process of claim 21, wherein said substance having surface activity has a number average molecular weight of 500 to 8,000.

23. The process of claim 21, wherein said hydrophobic porous membrane comprises polysulfone as the main structural component.

24. A process for suppressing blood cell adhesion by using medical equipment having a hydrophobic surface, wherein the medical equipment comprises:

a hydrophobic part to be in contact with blood and a substance having surface activity, and

said substance having surface activity is adsorbed on said hydrophobic surface in an amount of 0.02 mg to 250 mg based on unit dry weight (g).

25. The process of claim 24, which comprises:

impregnating said hydrophobic part to be in contact with blood into a solution of said substance having surface activity.

26. The process of claim 24, wherein said hydrophobic part to be in contact with blood is a porous membrane.

27. The process of claim 25, which further comprises after impregnating in a solution of a substance having surface activity, rinsing with a solvent in which said substance having surface activity is soluble, thereby eluting excess substance having surface activity.

28. The process of claim 24, wherein said substance having surface activity has a number average molecular weight of 500 to 8,000.

29. The process of claim 24, wherein said substance having surface activity is a nonionic surfactant.

30. The process of claim 29, wherein said nonionic surfactant is a polyoxyethylene sorbitan surfactant.

31. The process of claim 30, wherein said polyoxyethylene sorbitan surfactant is at least one member selected from the group consisting of polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan tristearate and polyoxyethylene sorbitan monooleate.

32. The process of claim 24, wherein said substance having surface activity is one member selected from the group consisting of purified vitelline lecithin, highly purified vitelline lecithin and purified soybean lecithin.

33. The process of claim 24 wherein said substance having surface activity is hydrogenated polyoxyethylene castor oil.

34. The process of claim 26, wherein said hydrophobic porous membrane comprises polysulfone as the main structural component.